Ruiz et al. [38] reported that SREBP1 levels are significantly elevated in obese patients and animal models of obesity and type 2 diabetes, with other studies indicating that SREBP1 contributes to hepatic lipid accumulation and insulin resistance. The gene discussed is SREBF1; the disease is obesity due to melanocortin 4 receptor deficiency.